Prevention of nosocomial Staphylococcus aureus infections after rapid detection and eradication of S. aureus carriage in patients at risk: a randomised placebo controlled multi-center trial.

Trial Profile

Prevention of nosocomial Staphylococcus aureus infections after rapid detection and eradication of S. aureus carriage in patients at risk: a randomised placebo controlled multi-center trial.

Completed
Phase of Trial: Phase IV

Latest Information Update: 24 Oct 2010

At a glance

  • Drugs Chlorhexidine (Primary) ; Mupirocin (Primary)
  • Indications Nosocomial infections; Staphylococcal infections
  • Focus Therapeutic Use
  • Acronyms STEP
  • Most Recent Events

    • 15 Sep 2010 Primary endpoint results presented at the 50th Interscience Conference on Antimicrobial Agents and Chemotherapy
    • 16 Jan 2010 Status changed from planning to completed.
    • 07 Jan 2010 Results published in the New England Journal of Medicine.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top